Survey of the Application of the Korean Clinical Practice Recommendations on Breast Cancer Treatment: The Utility of the Korean Breast Cancer Society Guidelines.
10.4048/jbc.2012.15.2.239
- Author:
Geumhee GWAK
1
;
Hae Kyung LEE
;
Hee Jung KIM
;
Si Youn LEE
;
Yong Lai PARK
;
Jong Won LEE
;
Seung Gi KIM
;
Ho HUH
;
Hyukjai SHIN
;
Je Ryong KIM
;
Jin Seok AHN
;
Ju Hyuk SON
;
Il Gyun LEE
;
Woo Chan PARK
;
Sung Yong KIM
;
Sehwan HAN
;
Eun Sook LEE
Author Information
1. Department of Surgery, Inje University Sanggye Paik Hospital, Seoul, Korea.
- Publication Type:Review ; Clinical Trial
- Keywords:
Breast neoplasms;
Guideline;
Korea;
Surveys
- MeSH:
Aluminum Hydroxide;
Breast;
Breast Diseases;
Breast Neoplasms;
Carbonates;
Surveys and Questionnaires;
Delivery of Health Care;
Dietary Sucrose;
Electronic Mail;
Humans;
Korea;
Logic
- From:Journal of Breast Cancer
2012;15(2):239-243
- CountryRepublic of Korea
- Language:English
-
Abstract:
This survey was performed to analyze the usability of the third edition of the Korean breast cancer clinical practice guidelines (KBCCPG) in clinical practice. We made a questionnaire composed of 18 general and 82 specific questions regarding benign breast disease (B; 1 question); non-invasive disease (N; 12 questions); early-stage disease (E; 26 questions); advanced disease (A; 24 questions); and metastatic (M) breast cancer-related problems (19 questions). A total of 100 questionnaires, with a link to an online survey, were delivered via e-mail to over 700 members of the Korean Breast Cancer Society (KBCS), and associated academy members, over 20 days between 26th February and 16th May 2010. Out of 270 respondents who read the e-mail, 96 answered the questionnaire. Participants included 87 surgical oncologists, 5 radiation oncologists, 2 oncoplastic surgeons, 1 pathologist, and 1 medical oncologist. The third KBCCPG were perceived as differing from the second guidelines in terms of the level of clinical evidence required before choosing a recommendation. For the progress of the KBCCPG, the guideline committee should try to reinforce all courses of guideline development with several elements including data from clinical trials of Korean breast cancer patients, securing a multidisciplinary approach, developing consistent and reasonable processes for each step of the revision of the guidelines, induction of liberal scientific and ethical discussion about all issues with all KBCS members. The cost-effectiveness of healthcare and the logical development of the KBCCPG would also be ensured. Timely updates of the clinical guidelines for breast cancer treatment are essential to facilitate optimal decision-making in daily practice, and to ensure adequate patient feedback.
